RepAir develops a Direct Air Capture solution based on a proprietary electrochemical cell technology.
RepAir has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
RepAir's investors include Extantia Capital, Israel Innovation Authority, Ormat Technologies, Counteract, Zero Carbon Capital.
RepAir is headquartered in Yoqne`am `illit, Israel.
RepAir develops a Direct Air Capture solution based on a proprietary electrochemical cell technology.
RepAir is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RepAir — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/repair. Accessed September 14, 2026.
VCBacked. (2025). RepAir — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/repair
{{cite web |title=RepAir — Funding & Investors |url=https://www.vcbacked.co/company/repair |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated